KRNY:NASDAQKearny Financial Analysis
Data as of 2026-05-25 - not real-time
$8.20
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Kearny Financial is trading at $8.20, comfortably above its 20‑day ($8.07) and 50‑day ($7.82) simple moving averages and well above the 200‑day SMA ($7.26), indicating a solid bullish bias. The MACD line sits above its signal line and a modest positive histogram (bullish) reinforces momentum, while the RSI at 57.5 suggests the stock is not yet overbought. Price action remains between a clear support zone at $7.47 and resistance near $8.27, with stable volume and a 30‑day volatility of 27.5% that, combined with a beta of 0.84, points to moderate market sensitivity. The market’s “Extreme Greed” sentiment (Fear‑Greed Index 91.66) further fuels short‑term upside potential.
Fundamentally, KRNY trades at a forward PE of ~10.4 versus the industry average of 16.8, and a price‑to‑book of 0.68, flagging it as undervalued. Revenue growth is robust at 17.5% YoY, and profit margins exceed 20%, delivering an attractive dividend yield of 5.37% with a payout ratio of 77%. Analysts project a median target of $9, implying roughly a 10% upside, though the balance sheet shows high debt ($1.06 B) relative to market cap, warranting caution on leverage.
Fundamentally, KRNY trades at a forward PE of ~10.4 versus the industry average of 16.8, and a price‑to‑book of 0.68, flagging it as undervalued. Revenue growth is robust at 17.5% YoY, and profit margins exceed 20%, delivering an attractive dividend yield of 5.37% with a payout ratio of 77%. Analysts project a median target of $9, implying roughly a 10% upside, though the balance sheet shows high debt ($1.06 B) relative to market cap, warranting caution on leverage.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Bullish technical setup (price above SMAs, bullish MACD)
- Undervalued valuation metrics (PE, PB)
- Attractive dividend yield with sustainable payout
Medium Term
1–3 yearsNeutral
Model confidence: 8/10
Key Factors
- Continued revenue growth and solid operating margins
- Potential upside toward analyst target of $9
- Elevated leverage requiring monitoring
Long Term
> 3 yearsNeutral
Model confidence: 7/10
Key Factors
- Stable dividend income for income‑focused investors
- Moderate credit and regulatory risk inherent to regional banks
- Valuation still below peer averages, offering margin of safety
Key Metrics & Analysis
Financial Health
Revenue Growth17.50%
Profit Margin21.02%
P/E Ratio14.4
ROE4.75%
ROA0.47%
P/B Ratio0.7
Op. Cash Flow$31.8M
Industry P/E16.8
Technical Analysis
TrendBullish
RSI57.5
Support$7.47
Resistance$8.27
MA 20$8.07
MA 50$7.82
MA 200$7.26
MACDBullish
VolumeStable
Fear & Greed Index91.66
Valuation
Target Price$9.00
Upside/Downside9.76%
GradeUndervalued
TypeBlend
Dividend Yield5.37%
Risk Assessment
Beta0.84
Volatility27.53%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.